ClinicalTrials.Veeva

Menu

Transoesophageal Echocardiography in Liver Transplantation

University of Zurich (UZH) logo

University of Zurich (UZH)

Status

Completed

Conditions

End Stage Liver Disease

Treatments

Behavioral: Transoesophageal echocardiography

Study type

Observational

Funder types

Other

Identifiers

NCT00547924
StV 11-2006

Details and patient eligibility

About

Severe hypotension during reperfusion in liver transplantation is a frequent adverse event. Rare data exist so far about pathophysiology of this phenomenon. The exact role of left ventricular function, which might be impaired causing hypotension, has not been elucidated during the period of reperfusion.

Goal of this study is to:

  • perform transesophageal echocardiography in order to assess systolic and diastolic left ventricular function during reperfusion
  • determine inflammatory mediators in the plasma which could cause left ventricular dysfunction

Enrollment

17 estimated patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients on waiting list for liver transplantation.
  • Age: 18-75 years.

Exclusion criteria

  • Strictures, tumours and diverticula of the oesophagus.
  • History of oesophageal varices with recent bleeding.
  • Oesophageal varices and prothrombin time less than 20% or platetlets les than 30000/ml.
  • Instable cervical spine.
  • Involvement in other studies.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems